Skip to content

Drug interactions

Dexlansoprazole + Tecovirimat

Severity: Minor

Dexlansoprazole and Tecovirimat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tecovirimat weakly inhibits CYP2C19 and weakly induces CYP3A4, so effects on dexlansoprazole are small and may partly offset each other. A meaningful change in PPI effect is unlikely.

What this interaction means in plain words

Dexlansoprazole and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dexlansoprazole belongs to Gastrointestinal Tract; Tecovirimat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Weak inhibition of CYP2C19 and weak induction of CYP3A4 by tecovirimat could alter dexlansoprazole metabolism slightly.

What to do

No adjustment is needed; monitor symptom control if the combination is used for a long time.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dexlansoprazole and Tecovirimat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dexlansoprazole with Tecovirimat?

MediHelp rates the interaction as minor. Dexlansoprazole and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tecovirimat weakly inhibits CYP2C19 and weakly induces CYP3A4, so effects on dexlansoprazole are small and may partly offset each other. A meaningful change in PPI effect is unlikely.

How serious is the interaction between Dexlansoprazole and Tecovirimat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No adjustment is needed; monitor symptom control if the combination is used for a long time.

What other medicines interact with Dexlansoprazole?

MediHelp also lists interactions of Dexlansoprazole with, for example, Mavacamten, Rilpivirine, Acalabrutinib. The full list is on the Dexlansoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in